Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
14,285 | $3.3961 | $48,513 | 373,171 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
14,547 | $3.3961 | $49,403 | 365,113 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:06 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
7,558 | $3.3961 | $25,668 | 281,442 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
172,000 | $0 | 373,171 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
172,000 | $0 | 365,113 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:06 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
190,000 | $0 | 281,442 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:06 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer |
70,200 | $0 | 83,100 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:05 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 08:17 am |
N/A 2031-02-16 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
80,200 | $0 | 80,200 (Direct) |
View |
Ownership |
2021-01-28 5:03 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer |
0 | $0 | 54,900 (Direct) |
View |